Deep Learning based Models for Drug-Target Interactions
The typical drug development approach is slow, costly, and fraught with failure - scientists examine millions of compounds, but only a few make it to preclinical or clinical testing. Machine learning (ML), a subset of AI, is a fast-expanding subject many pharmaceutical businesses increasingly utili...
Saved in:
Main Authors: | Ali K. Abdul Raheem, Ban N. Dhannoon |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Baghdad, College of Science for Women
2024-11-01
|
Series: | مجلة بغداد للعلوم |
Subjects: | |
Online Access: | https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/9212 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effective Detection of Malicious Uniform Resource Locator (URLs) Using Deep-Learning Techniques
by: Yirga Yayeh Munaye, et al.
Published: (2025-06-01) -
DeepInsulin-Net: A Deep Learning Model for Identifying Drug Interactions Leading to Specific Insulin-Related Adverse Events
by: Muhammed Ali Pala
Published: (2025-06-01) -
Identify drug-drug interactions via deep learning: A real world study
by: Jingyang Li, et al.
Published: (2025-06-01) -
Application of artificial intelligence large language models in drug target discovery
by: Xinyu Liu, et al.
Published: (2025-07-01) -
Anti-scarring drug discovery: potential targets and therapeutic opportunities
by: Meiling Feng, et al.
Published: (2025-12-01)